The Relationship Between Copeptin And Cellular Oxidative Damage By Xanthine Oxidase, Heme Oxygenase-1 And Nitric Oxide Synthase In Metabolic Syndrome Patients
DOI:
https://doi.org/10.46966/msjar.v4i3.145Keywords:
MetS, Copeptin, Xanthine Oxidase, Heme Oxygenase-1, Nitric Oxide synthase, Insulin resistanceAbstract
Background: Metabolic syndrome(MetS) is the medical term for a cluster of metabolic abnormalities that increases in individuals risk of T2DM and CVD. The component of MetS are glucose intolerance, obesity, hypertension and dyslipidemia. An insulin resistance is the key phase of metabolic syndrome constitutes the major risk factor for the development of diabetes mellitus. Objectives: The present study aimed to comprise Copeptin, Xanthine Oxidase, Heme Oxygenase-1 and Nitric Oxide synthase in addition to insulin resistance values and lipid profile among two study groups, metabolic syndrome patients and Controls group. Subjects: The present study included 50 metabolic syndrome patients and 50 individuals as healthy control. Methods: current study investigated the association between Copeptin, Xanthine Oxide, Heme Oxygenase and Nitric Oxide Synthase with development risk effect of endothelial dysfunction in MetS patients by applying ELISA kit method. Results: current work showed a highly significant variations among study groups, except for age.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Athraa Adnan Mahdi, Elham Abed Mahdi
This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
